The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of prior treatment with anti-EGFR monoclonal antibodies with downregulation of circulating TRAIL and upregulation of EGFR and VEGF family ligands in metastatic colorectal cancer.
Michael Sangmin Lee
No relevant relationships to disclose
Christopher Hanyoung Lieu
No relevant relationships to disclose
Michael J. Overman
No relevant relationships to disclose
Cathy Eng
No relevant relationships to disclose
Jeffrey Morris
No relevant relationships to disclose
Zhi-Qin Jiang
No relevant relationships to disclose
Maria Morelli
No relevant relationships to disclose
John Heymach
No relevant relationships to disclose
Hai T. Tran
No relevant relationships to disclose
Scott Kopetz
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb